Lu, L; Xiong, W; Liu, D; Liu, J; Yang, D; Li, N; Mu, J; ... Zhou, D; + view all Lu, L; Xiong, W; Liu, D; Liu, J; Yang, D; Li, N; Mu, J; Guo, J; Li, W; Wang, G; Gao, H; Zhang, Y; Lin, M; Chen, L; Shen, S; Zhang, H; Sander, JW; Luo, J; Chen, S; Zhou, D; - view fewer (2020) New-onset acute symptomatic seizure and risk factors in Corona Virus Disease 2019: A Retrospective Multicenter Study. Epilepsia , 61 (6) e49-e53. 10.1111/epi.16524.

Preview

Text epi.16524.pdf - Accepted Version Download (6MB) | Preview

Abstract

Our aim was to clarify the incidence and risk of acute symptomatic seizures in people with coronavirus disease 2019 (COVID-19). This multicenter retrospective study enrolled people with COVID-19 from 18 January to 18 February 2020 at 42 government-designated hospitals in Hubei province, the epicenter of the epidemic in China; Sichuan province; and Chongqing municipality. Data were collected from medical records by 11 neurologists using a standard case report form. A total of 304 people were enrolled, of whom 108 had a severe condition. None in this cohort had a known history of epilepsy. Neither acute symptomatic seizures or status epilepticus were observed. Two people had seizure-like symptoms during hospitalization due to acute stress reaction and hypocalcemia, Eighty-four (27%) had brain insults or metabolic imbalances during the disease course known to increase the risk of seizures. There was no evidence suggesting an additional risk of acute symptomatic seizures in people with COVID-19.Neither the virus or potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID-19.

Download activity - last month

Export as CSVXMLJSON

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item